Elisa Salvati
Elisa Salvati
The Children's Hospital of Philadelphia
Verified email at EMAIL.CHOP.EDU
Title
Cited by
Cited by
Year
Versatile and efficient targeting using a single nanoparticulate platform: application to cancer and Alzheimer’s disease
B Le Droumaguet, J Nicolas, D Brambilla, S Mura, A Maksimenko, ...
ACS nano 6 (7), 5866-5879, 2012
1282012
Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model
E Salvati, F Re, S Sesana, I Cambianica, G Sancini, M Masserini, ...
International journal of nanomedicine 8, 1749, 2013
972013
Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide
F Re, I Cambianica, S Sesana, E Salvati, A Cagnotto, M Salmona, ...
Journal of biotechnology 156 (4), 341-346, 2011
952011
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood–brain-barrier: Implications for therapy ofá…
L Bana, S Minniti, E Salvati, S Sesana, V Zambelli, A Cagnotto, A Orlando, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (7), 1583-1590, 2014
922014
A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
V Parthsarathy, PL McClean, C H÷lscher, M Taylor, C Tinker, G Jones, ...
PLoS One 8 (1), e54769, 2013
722013
Nanosensors for early cancer detection and for therapeutic drug monitoring
E Salvati, F Stellacci, S Krol
Nanomedicine 10 (23), 3495-3512, 2015
432015
Functionalization with TAT-peptide enhances blood-brain barrier crossing in vitro of nanoliposomes carrying a curcumin-derivative to bind amyloid-β peptide
G Sancini, M Gregori, E Salvati, I Cambianica, F Re, F Ornaghi, M Canovi, ...
OMICS Publishing Group 4 (3), 1-8, 2013
372013
Ceramides and sphingomyelinases in senile plaques
M Panchal, M Gaudin, AN Lazar, E Salvati, I Rivals, S Ayciriex, ...
Neurobiology of Disease 65, 193-201, 2014
352014
Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide
M Gregori, M Taylor, E Salvati, F Re, S Mancini, C Balducci, G Forloni, ...
Nanomedicine: Nanotechnology, Biology and Medicine 13 (2), 723-732, 2017
292017
Multifunctional liposomes interact with Abeta in human biological fluids: therapeutic implications for Alzheimer's disease
E Conti, M Gregori, I Radice, F Da Re, D Grana, F Re, E Salvati, ...
Neurochemistry international 108, 60-65, 2017
172017
Novel antitransferrin receptor antibodies improve the blood–brain barrier crossing efficacy of immunoliposomes
M Gregori, A Orlando, F Re, S Sesana, L Nardo, D Salerno, F Mantegazza, ...
Journal of Pharmaceutical Sciences 105 (1), 276-283, 2016
172016
Serotonin and catecholamines in the development and progression of heart valve diseases
E Goldberg, JB Grau, JH Fortier, E Salvati, RJ Levy, G Ferrari
Cardiovascular research 113 (8), 849-857, 2017
162017
FM19G11-loaded gold nanoparticles enhance the proliferation and self-renewal of ependymal stem progenitor cells derived from ALS mice
S Marcuzzo, D Isaia, S Bonanno, C Malacarne, P Cavalcante, A Zacheo, ...
Cells 8 (3), 279, 2019
42019
pH-Mediated molecular differentiation for fluorimetric quantification of chemotherapeutic drugs in human plasma
LA Serrano, Y Yang, E Salvati, F Stellacci, S Krol, S Guldin
Chemical Communications 54 (12), 1485-1488, 2018
32018
Liposomes functionalized with GT1b ganglioside with high affinity for amyloid beta-peptide
E Salvati, M Masserini, S Sesana, S Sonnino, F Re, M Gregori
J Alzheimers Dis 29 (Suppl 1), 33-36, 2012
32012
Multi-functionalized nanoparticles for therapy and diagnosis of alzheimer's disease
E Salvati
UniversitÓ degli Studi di Milano-Bicocca, 2013
22013
Nanoliposomes functionalized to overcome the blood-brain barrier and to target amyloid-βpeptide: the chemical design affects the permeability across a model barrier
E Salvati, F Re, S Sesana, I Cambianica, G Sancini, M Masserini, ...
Multi-functionalized nanoparticles for therapy and diagnosis of Alzheimer’sá…, 2010
12010
Inhibition and down regulation of the serotonin transporter contribute to the progression of degenerative mitral regurgitation
RJ Levy, E Fitzpatrick, E Castillero, HJ Shukla, VV Inamdar, AE Aghali, ...
bioRxiv, 2020
2020
Nanoparticle-based strategy to cross the BBB: the potential for the therapy of Alzheimer’s disease
S MANCINI, C Balducci, M GREGORI, E Salvati, G SANCINI, L Colombo, ...
CRS Italy local Chapter, Micro and Nanotechnology to overcome biologicalá…, 2015
2015
Ceramides and sphingomyelinases in senile plaques
S Ayciriex, M Panchal, M Gaudin, A Lazar, E Salvati, I Rivals, L Dauphinot, ...
2014
The system can't perform the operation now. Try again later.
Articles 1–20